lobbying_filings_raw: b9f69c38-63e2-4c4a-8370-231610804ab0
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence | income_amount | expense_amount |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| b9f69c38-63e2-4c4a-8370-231610804ab0 | Q1 | 293335 | THE NICKLES GROUP, LLC | 213700 | AMGEN | 2022 | first_quarter | 2022-04-12T17:46:48-04:00 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/b9f69c38-63e2-4c4a-8370-231610804ab0/", "filing_uuid": "b9f69c38-63e2-4c4a-8370-231610804ab0", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2022, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/b9f69c38-63e2-4c4a-8370-231610804ab0/print/", "filing_document_content_type": "text/html", "income": "50000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Mary Beth Savary Taylor", "dt_posted": "2022-04-12T17:46:48-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "601 13th St. NW", "registrant_address_2": "Suite 250 N", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 293335, "url": "https://lda.senate.gov/api/v1/registrants/293335/", "house_registrant_id": 37338, "name": "THE NICKLES GROUP, LLC", "description": "Consulting firm.", "address_1": "601 13th St. NW", "address_2": "Suite 250 N", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "KATHLEEN MCGHEE", "contact_telephone": "+1 202-742-6990", "dt_updated": "2026-01-14T08:51:26.922313-05:00"}, "client": {"id": 213700, "url": "https://lda.senate.gov/api/v1/clients/213700/", "client_id": 1005608, "name": "AMGEN", "general_description": "Biotechnology.", "client_government_entity": null, "client_self_select": false, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2022-01-01"}, "lobbying_activities": [{"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "H.R. 5376, The Build Better Back Act and issues regarding drug pricing. Issues regarding ESRD payments. H.R. 3517 / S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 26331, "prefix": null, "prefix_display": null, "first_name": "MARY", "nickname": null, "middle_name": "BETH", "last_name": "SAVARY TAYLOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 89965, "prefix": null, "prefix_display": null, "first_name": "GREG", "nickname": null, "middle_name": null, "last_name": "D'ANGELO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Monitored S. 3799, PREVENT Pandemics Act. Monitored issues related to FDA user fee agreements. Issues regarding timely access to medications.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 26331, "prefix": null, "prefix_display": null, "first_name": "MARY", "nickname": null, "middle_name": "BETH", "last_name": "SAVARY TAYLOR", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 89965, "prefix": null, "prefix_display": null, "first_name": "GREG", "nickname": null, "middle_name": null, "last_name": "D'ANGELO", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "GOV", "general_issue_code_display": "Government Issues", "description": "H.R. 5376, The Build Better Back Act and issue regarding drug pricing. Issues regarding ESRD payments. H.R. 3517, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. Monitored the FDA user fee agreements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 103387, "prefix": null, "prefix_display": null, "first_name": "BRETT", "nickname": null, "middle_name": null, "last_name": "BAKER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 37338 | CA | CA | US | US | Biotechnology. | 0 | 50000.0 |